Regulation (EU) 2024/996 of the European Commission, of 04/03/2024, amends Regulation (EC) No. 1223/2009 of the European Parliament and of the Council with regard to the use of 3-(4'-methylbenzylidene )-camphor (4-MBC, CAS# 36861-47-9/38102-62-4) as it has the potential for endocrine disruption in cosmetic products, and has effects on both the thyroid system and estrogen and it is not possible to determine a maximum concentration for safe use of the substance.…
